Dataset Information

Practice of dialysis access interventional nephrology procedures in the Asia-Pacific region: Getting lay of the land.

ABSTRACT:

Aim

This cross-sectional survey aimed to determine the prevalence of Interventional Nephrology (IN) practice amongst nephrologists in the Asia-Pacific Region (APR), specifically related to dialysis access (DA).

Methods

The Association of VA and intervenTionAl Renal physicians (AVATAR) Foundation from India conducted a multinational online survey amongst nephrologists from the Asia-Pacific to determine the practice of IN in the planning, creation, and management of dialysis access. The treatment modalities, manpower and equipment availability, monthly cost of treatment, specifics of dialysis access interventions, and challenges in the training and practice of IN by nephrologists were included in the survey.

Results

Twenty-one countries from the APR participated in the survey. Nephrologists from 18 (85.7%) countries reported performing at least one of the basic dialysis access-related IN procedures, primarily the placement of non-tunnelled central catheters (n-TCC; 71.5%). Only 10 countries (47.6%) reported having an average of <4% of nephrologists performing any of the advanced IN access procedures, the most common being the placement of a peritoneal dialysis (PD) catheter (20%). Lack of formal training (57.14%), time (42.8%), incentive (38%), institutional support (38%), medico-legal protection (28.6%), and prohibitive cost (23.8%) were the main challenges to practice IN. The primary obstacles to implementing the IN training were a lack of funding and skilled personnel.

Conclusion

The practice of dialysis access-related IN in APR is inadequate, mostly due to a lack of training, backup support, and economic constraints, whereas training in access-related IN is constrained by a lack of a skilled workforce and finances.

SUBMITTER: Jasuja S

PROVIDER: S-EPMC7615839 | biostudies-literature | 2023 Dec

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

Practice of dialysis access interventional nephrology procedures in the Asia-Pacific region: Getting lay of the land.

Jasuja Sanjiv S Gallieni Maurizio M Jha Vivekanand V Vachharajani Tushar T Bhalla A K AK Tan Jackson J Tan Cheih Suai CS Basnet Nabin Bahadur NB Herath Nalaka N Hai An Ha Phan HP Kim Yong Soo YS Kim Yaeni Y SampathKumar Krishnaswamy K Sahay Manisha M Ramachandran Raja R Alexander Suceena S Bhargava Vinant V Balasubramaniam J J Voss David D Ogbac Fredeick E FE Gunawan Atma A Goh Bak Leong BL Lin Chih-Ching CC Khan Jamshaid J Shiham Ibrahim I Ayub Haroon H Hein Min Aung MA Iqbal Sarwar S Srisawat Nattachai N Gao Bihu B Sajiv Cherian C Wilkinson Catherine C Pichthida Thim T Rana D S DS Sagar Gaurav G Bahl Anupam A Tawakley Samir S Gaur Mragank M

Nephrology (Carlton, Vic.) 20230911 12

<h4>Aim</h4>This cross-sectional survey aimed to determine the prevalence of Interventional Nephrology (IN) practice amongst nephrologists in the Asia-Pacific Region (APR), specifically related to dialysis access (DA).<h4>Methods</h4>The Association of VA and intervenTionAl Renal physicians (AVATAR) Foundation from India conducted a multinational online survey amongst nephrologists from the Asia-Pacific to determine the practice of IN in the planning, creation, and management of dialysis access. ...[more]

PMID: 37697492

Similar Datasets

Project description:Background and aimsTo improve upon the estimation of 10-year cardiovascular disease (CVD) event risk for individuals without prior CVD or diabetes mellitus in the Asia-Pacific region by systematic recalibration of the SCORE2 risk algorithm.MethodsThe sex-specific and competing risk-adjusted SCORE2 algorithms were systematically recalibrated to reflect CVD incidence observed in four Asia-Pacific risk regions, defined according to country-level World Health Organization age- and sex-standardized CVD mortality rates. Using the same approach as applied for the original SCORE2 models, recalibration to each risk region was completed using expected CVD incidence and risk factor distributions from each region.ResultsRisk region-specific CVD incidence was estimated using CVD mortality and incidence data on 8 405 574 individuals (556 421 CVD events). For external validation, data from 9 560 266 individuals without previous CVD or diabetes were analysed in 13 prospective studies from 12 countries (350 550 incident CVD events). The pooled C-index of the SCORE2 Asia-Pacific algorithms in the external validation datasets was .710 [95% confidence interval (CI) .677-.744]. Cohort-specific C-indices ranged from .605 (95% CI .597-.613) to .840 (95% CI .771-.909). Estimated CVD risk varied several-fold across Asia-Pacific risk regions. For example, the estimated 10-year CVD risk for a 50-year-old non-smoker, with a systolic blood pressure of 140 mmHg, total cholesterol of 5.5 mmol/L, and high-density lipoprotein cholesterol of 1.3 mmol/L, ranged from 7% for men in low-risk countries to 14% for men in very-high-risk countries, and from 3% for women in low-risk countries to 13% for women in very-high-risk countries.ConclusionsThe SCORE2 Asia-Pacific algorithms have been calibrated to estimate 10-year risk of CVD for apparently healthy people in Asia and Oceania, thereby enhancing the identification of individuals at higher risk of developing CVD across the Asia-Pacific region.

Dataset Information

Practice of dialysis access interventional nephrology procedures in the Asia-Pacific region: Getting lay of the land.

Aim

Methods

Results

Conclusion

Publications

Practice of dialysis access interventional nephrology procedures in the Asia-Pacific region: Getting lay of the land.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets